We won't stop until we find and fund the next
five
healthtech unicorns for women
Top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately
— McKinsey & Company, 2025
Femtech is forecasted to reach $60bn+ TAM by 2027
-Allied Market Research, 2023
closing the women’s health gap could unlock $400 billion in global GDP annually by 2040
-World Economic Forum, 2025
recent news
Women's Health Founders:
Intimate Funding & Connection Session
Women's Health Morning Walk & Coffee